Cardiovascular Systems In... (CSII)
NASDAQ: CSII
· Real-Time Price · USD
20.00
0.03 (0.15%)
At close: Apr 27, 2023, 10:00 PM
Cardiovascular Systems Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | 239.84M | 237.53M | 236.22M | 244.71M | 251.76M | 256.8M | 258.97M | 230.53M | 228.43M | 232.6M |
Cost of Revenue | 66.22M | 65.83M | 63.44M | 67.81M | 67.03M | 62.88M | 61.13M | 50.64M | 48.85M | 48.65M |
Gross Profit | 173.63M | 171.69M | 172.78M | 176.91M | 184.74M | 193.92M | 197.84M | 179.89M | 179.58M | 183.95M |
Operating Income | -38.56M | -38.59M | -35.81M | -31.23M | -27.23M | -18.39M | -11.93M | -21.75M | -18.84M | -22.5M |
Interest Income | 2.46M | 1.43M | 817K | 666K | 326K | 398K | 499K | 566K | 840K | 1.22M |
Pretax Income | -37.73M | -38.79M | -36.62M | -32.2M | -28.55M | -19.64M | -13.17M | -23.01M | -19.91M | -23.28M |
Net Income | -37.87M | -38.95M | -36.93M | -32.53M | -28.87M | -19.96M | -13.42M | -23.3M | -20.19M | -23.53M |
Selling & General & Admin | 174.39M | 173.15M | 170.53M | 169.65M | 169.41M | 169.07M | 167.5M | 156.75M | 156.69M | 163.5M |
Research & Development | 36.41M | 35.75M | 36.72M | 37.19M | 41.3M | 42.03M | 41.06M | 43.66M | 40.46M | 41.64M |
Other Expenses | 1.38M | 1.38M | 1.04M | 692K | 346K | n/a | n/a | n/a | -107K | -90K |
Operating Expenses | 212.19M | 210.29M | 208.59M | 208.14M | 211.97M | 212.31M | 209.78M | 201.65M | 198.42M | 206.44M |
Interest Expense | 1.63M | 1.63M | 1.63M | 1.64M | 1.64M | 1.65M | 1.74M | 1.82M | 1.91M | 2M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 278.4M | 276.12M | 272.03M | 275.94M | 279M | 275.19M | 270.91M | 252.29M | 247.27M | 255.1M |
Income Tax Expense | 141K | 155K | 310K | 325K | 325K | 325K | 252K | 291K | 275K | 256K |
Shares Outstanding (Basic) | 39.66M | 39.61M | 39.35M | 39.29M | 39.2M | 39.09M | 38.93M | 38.91M | 38.81M | 38.68M |
Shares Outstanding (Diluted) | 39.66M | 39.61M | 39.35M | 39.29M | 39.2M | 39.09M | 38.93M | 38.91M | 38.81M | 38.68M |
EPS (Basic) | -0.97 | -1 | -0.95 | -0.84 | -0.74 | -0.51 | -0.35 | -0.64 | -0.57 | -0.67 |
EPS (Diluted) | -0.97 | -1 | -0.95 | -0.84 | -0.74 | -0.51 | -0.35 | -0.64 | -0.57 | -0.67 |
EBITDA | -35.65M | -34.67M | -32.46M | -27.93M | -23.1M | -14.41M | -8.96M | -18.75M | -16.68M | -21.19M |
EBIT | -36.1M | -37.16M | -34.99M | -30.56M | -26.91M | -17.99M | -11.43M | -21.19M | -18M | -21.28M |
Depreciation & Amortization | 2.92M | 3.92M | 3.3M | 3.26M | 3.97M | 3.68M | 2.72M | 2.74M | 2.02M | 1.3M |